rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-10
|
pubmed:abstractText |
Combined hepatocellular cholangiocarcinoma (CHC) is a rare form of primary liver cancer, showing a mixture of hepatocellular and biliary features. Data suggest that most CHC arise from hepatic progenitor cells (HPCs). The aim was to investigate the origin of CHC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1365-2559
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
224-32
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18184271-Adult,
pubmed-meshheading:18184271-Aged,
pubmed-meshheading:18184271-Bile Ducts, Intrahepatic,
pubmed-meshheading:18184271-Carcinoma, Hepatocellular,
pubmed-meshheading:18184271-Cell Transformation, Neoplastic,
pubmed-meshheading:18184271-Cholangiocarcinoma,
pubmed-meshheading:18184271-Female,
pubmed-meshheading:18184271-Hepatocytes,
pubmed-meshheading:18184271-Humans,
pubmed-meshheading:18184271-Keratin-19,
pubmed-meshheading:18184271-Keratin-7,
pubmed-meshheading:18184271-Liver Neoplasms,
pubmed-meshheading:18184271-Male,
pubmed-meshheading:18184271-Middle Aged,
pubmed-meshheading:18184271-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:18184271-Receptor, PAR-1,
pubmed-meshheading:18184271-Stem Cells
|
pubmed:year |
2008
|
pubmed:articleTitle |
Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
|
pubmed:affiliation |
Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|